Ticker Details
Spyre Therapeutics, Inc.
IPO Date:	April 4, 2016
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.17 | 3.62%
Avg Daily Range (30 D):	$2.60 | 2.61%
Avg Daily Range (90 D):	$2.63 | 3.16%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.75M
Avg Daily Volume (90 D):	.99M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	36
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	1,587
Avg Institutional Trade:	$3.2M
Avg Institutional Trade (30 D):	$5.72M
Avg Institutional Trade (90 D):	$6.12M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.09M
Avg Closing Trade (30 D):	$13.34M
Avg Closing Trade (90 D):	$16.35M
Avg Closing Volume:	129.39K

News

Apr 15, 2026 @ 2:38 AM Spyre Therapeutics Announces Pricing of Upsized $4... Source: Not Specified

Apr 13, 2026 @ 8:46 PM Spyre Therapeutics Announces Proposed Public Offer... Source: Globe Newswire

Apr 13, 2026 @ 8:46 PM Spyre Therapeutics Announces Proposed Public Offer... Source: Not Specified

Apr 13, 2026 @ 11:00 AM Spyre Announces Potential Best-in-Class SPY001 Par... Source: Spyre Therapeutics, Inc.

Mar 19, 2026 @ 2:34 AM Signal or Noise: What VR Adviser's Spyre Theraputi... Source: Seena Hassouna

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS
Diluted EPS		$-.35	$-.74
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-178.92M	$-36.2M	$-69.01M
Operating Income / Loss	$-201.34M	$-41.64M	$-45.64M
Cost of Revenue
Net Cash Flow	$80.35M	$64.82M	$11.46M
PE Ratio

Splits
Sep 08, 2023	1:25